Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A [Phase 4]
A Phase 4 trial comparing an immunosuppressive regimen including everolimus with reduced cyclosporine versus mycophenolic acid with standard…
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating nilotinib for cytomegalovirus prophylaxis and treatment following allogeneic hematopoietic stem cell trans…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Clinical Performance Evaluation of DxN CMV Assay
Clinical trial update notes the terminated status of a study evaluating the performance of Beckman Coulter's DxN CMV Assay for cytomegalovir…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient [Phase 1]
Phase 1 trial evaluating the tolerability and safety of BD03 to prevent cytomegalovirus and BK virus reactivation in kidney transplant recip…
-
CLINICAL_TRIALS trial_result · 2018-04-03Clinical Trial Update: Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV [Phase 1]
Phase 1 trial assessing safety and immunogenicity of an HCMV vaccine by Hookipa Biotech has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis
Clinical trial update notes a study on cytomegalovirus infection in patients with steroid-refractory ulcerative colitis, with the current tr…
-
CLINICAL_TRIALS trial_result · 2018-02-26Clinical Trial Update: Efficacy and Safety Study of CSJ148 in Stem Cell Transplant Patients [Phase 2]
Phase 2 trial update on CSJ148 in stem cell transplant patients assessing efficacy and safety for HCMV; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study [Phase 3]
Phase 3 clinical trial update for an immunoprophylactic adoptive cellular therapy targeting cytomegalovirus infection.
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Alternate Donor Study of Pre-Emptive Cellular Therapy [Phase 2]
Phase 2 clinical trial update for pre-emptive cellular therapy using alternate donors in cytomegalovirus infection.
-
CLINICAL_TRIALS trial_result · 2017-12-02Clinical Trial Update: Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant [Phase 2]
A Phase 2 trial evaluating ganciclovir given by infusion and by mouth to treat cytomegalovirus infection in patients after donor bone marrow…
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV) [Phase 4]
Phase 4 trial completed evaluating whether a viral load threshold can guide treatment for cytomegalovirus infection (viraemia).
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response
The report provides long-term antibody response data from a cytomegalovirus glycoprotein B vaccine trial conducted by University College Lon…
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria [Phase 4]
A Phase 4 clinical trial comparing two tacrolimus-based immunosuppressant regimens with thymoglobulin induction in deceased-donor expanded-c…
-
CLINICAL_TRIALS trial_result · 2017-08-02Clinical Trial Update: Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus [Phase 1]
Phase 1 vaccine therapy study in healthy volunteers with or without prior exposure to cytomegalovirus has completed. The trial evaluated saf…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients [Phase 4]
Phase 4 clinical trial update evaluating valganciclovir to prevent cytomegalovirus infection in kidney and kidney/pancreas transplant recipi…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants [Phase 1]
Phase 1 trial evaluating CMV-specific cytotoxic T lymphocytes for CMV prophylaxis in recipients of allogeneic, T-cell depleted stem cell tra…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT [Phase 1]
Phase 1 trial evaluating CMV-specific donor lymphocyte infusions from 3-6/6 HLA-matched family members after nonmyeloablative allogeneic ste…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects [Phase 1]
Phase 1 study evaluating safety and immunogenicity of GlaxoSmithKline's cytomegalovirus vaccine in CMV-seronegative healthy male adults; the…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy [Phase 1]
Phase 1 study evaluating a cytomegalovirus vaccine therapy in cancer patients after donor stem cell transplant who have CMV infection refrac…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study on the Pharmacokinetics and Safety of Valcyte (Valganciclovir) in Pediatric Heart Transplant Recipients Less Than 4 Months of Age [Phase 1]
Phase 1 study assessing the pharmacokinetics and safety of valganciclovir (Valcyte) in pediatric heart transplant recipients under 4 months …
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant Recipients [Phase 2, Phase 3]
Phase 2/Phase 3 trial assessed valganciclovir syrup in pediatric solid organ transplant recipients for cytomegalovirus infection, with resul…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive
A completed clinical trial in CMV-positive lung transplant patients evaluated CMV-specific immune response using QuantiFeron and overall imm…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Cytomegalovirus (CMV) Infection in Pregnancy
The clinical trial investigating cytomegalovirus infection in pregnancy has completed, per the registry information.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence [Phase 4]
A Phase 4 clinical trial update assesses conversion to sirolimus for recurrence of cytomegalovirus infection. The study is sponsored by Hosp…
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Prediction of Cytomegalovirus (CMV) Reactivation in Intensive Care Unit (ICU) by Immunological Study
The NCT02843880 clinical trial studying immunological predictors of Cytomegalovirus infection reactivation in ICU patients was terminated.